430 results on '"Gambato, M"'
Search Results
2. Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
3. AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool
4. Impact of ISO score on oncological outcomes and survival in liver transplant candidates with hepatocellular carcinoma
5. Increased level of presepsin in patients with acutely decompensated cirrhosis predicts development of acute-on-chronic liver failure
6. Nationwide survey of liver transplantation for Primary Sclerosing Cholangitis in Italy
7. Recurrence of primary sclerosing cholangitis after liver transplantation: A single center data
8. OC.08.3 HCC RECURRENCE AFTER LIVER TRANSPLANTATION: THE VALIDATION OF RETREAT SCORE IN A SINGLE CENTER COHORT
9. T.11.1 ASSESSMENT OF PHYSICAL FRAILTY IN HOSPITALIZED PATIENTS WITH CIRRHOSIS: PRELIMINARY RESULTS FROM AN ONGOING PROSPECTIVE STUDY
10. Hepatitis D: A still relevant disease
11. T.07.2 THE IMPACT OF NUCLEOS(T)IDE ANALOGUES ON THE WAITING LIST
12. Long-term treatment with fibrates and ursodeoxycholic acid in people with Primary Sclerosing Cholangitis is safe and associated with persistent clinical and biochemical improvement
13. The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma
14. The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma
15. Liver Stiffness 1 Year After Transplantation Predicts Clinical Outcomes in Patients With Recurrent Hepatitis C
16. Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications
17. Polyclonal and monoclonal B lymphocytes response in HCV‐infected patients treated with direct‐acting antiviral agents
18. Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation
19. Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
20. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
21. Increased platelet aggregation in decompensated cirrhosis indicates higher risks of further decompensation and liver-related mortality
22. Nash up, virus down: how is changing the waiting list for liver transplantation: a single center experience from Italy
23. OC.04.8 IMPACT OF COVID-19 PANDEMIC ON REFERRAL OF PATIENTS WITH LIVER DISEASE TO A LIVER TRANSPLANT CENTER
24. PREDICTION OF RECURRENCE AFTER LIVER TRANSPLANTATION FOR HCC: VALIDATION OF THE AFP MODEL IN AN ITALIAN COHORT: 61
25. Progression of Hepatocellular Carcinoma Before Liver Transplantation: Dropout or Liver Transplantation?
26. De Novo Tumors Are a Major Cause of Late Mortality After Orthotopic Liver Transplantation
27. Prospective Validation of a New Priority Allocation Model for Liver Transplant Candidates: An Interim Analysis
28. Risk of Kaposi Sarcoma after Solid-Organ Transplantation: Multicenter Study in 4767 Recipients in Italy, 1970–2006
29. Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation
30. Analysis of clinical course of portal vein thrombosis in cirrhosis with hepatocellular carcinoma
31. Increased platelet aggregation in patients with cirrhosis and hepatocellular carcinoma: A new potential therapeutic target?
32. Italian practical clinical guidelines on cholangiocarcinoma: Part II, treatment
33. OC.05.3 ENDOTHELIAL DAMAGE IN THE PORTAL VEIN OF PATIENTS WITH CIRRHOSIS
34. T06.01.4 IMPACT OF PRE-TRANSPLANT SARCOPENIA ON SHORT TO MEDIUM TERM OUTCOME IN LIVER TRANSPLANT RECIPIENTS WITH AND WITHOUT HEPATOCELLULAR CARCINOMA
35. PC.01.5 INFECTIONS IN CIRRHOSIS: A CHANGING EPIDEMIOLOGIC SETTING
36. Long-term liver fibrosis and outcomes in HCV-infected solid organ transplant recipients after DAAs-induced viral eradication
37. Role of a dedicated referral system for patients with liver disease and potential indication for liver transplantation: prospective data from a single centre experience
38. Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection
39. Infection in cirrhosis: a changing epidemiologic setting
40. RISK OF KAPOSIʼS SARCOMA FOLLOWING SOLID ORGAN TRANSPLANTATION. A MULTICENTER STUDY IN 4767 RECIPIENTS: ITALY 1970-2006: O-321
41. Hepatitis C virus intrinsic molecular determinants may contribute to the development of cholestatic hepatitis after liver transplantation
42. P.04.10 HBV-HDV RELATED LIVER DISEASE AS INDICATION FOR LIVER TRANSPLANTATION: A SINGLE CENTER STUDY
43. P.04.13 THE ROLE OF IMMUNE PROFILE IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS IN PREDICTING MORTALITY AND THE DEVELOPMENT OF INFECTIONS: A PROSPECTIVE EVALUATION
44. P.04.17 IMPACT OF DAA IN PATIENTS WHO UNDERGOING SOLID ORGAN TRANSPLANTATION
45. P.04.7 PREVALENCE OF DE NOVO METABOLIC SYNDROME AND ITS RISK FACTORS IN A LIVER TRANSPLANTED POPULATION: A PROSPECTIVE STUDY
46. OC.01.2 DE NOVO NEOPLASMS AFTER LIVER TRANSPLANTATION: DONOR GENDER AND AGE INFLUENCE
47. The role of immune profile in patients with severe alcoholic hepatitis in predicting mortality and the development of infections: a prospective evaluation
48. Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy
49. The role of delta creatinine and serum albumin in predicting mortality in patients with severe alcoholic hepatitis and infection
50. De novo neoplasms after liver transplantation: donor gender and age influence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.